Search
for
Sort by
Research 61–90 of 78
- Table_1.docx
- Androgen sensitivity gateway to COVID‐19 disease severity
- Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The “Gabrin sign”
- Organoid technology for tissue engineering
- Hypogonadism as a Reversible Cause of Torsades de Pointes in Men
- Alleviation of Multidrug Resistance by Flavonoid and Non-Flavonoid Compounds in Breast, Lung, Colorectal and Prostate Cancer
- Enriching Proteolysis Targeting Chimeras with a Second Modality: When Two Are Better Than One
- Proteolysis‐Targeting Chimera (PROTAC): Current Applications and Future Directions
- Impact of Medical Castration on Malignant Arrhythmias in Patients With Prostate Cancer
- Androgens in cervical cancer: Their role in epidemiology and biology
- Cancer-Related Alopecia: From Etiologies to Global Management
- A Review of the Characteristics of Clinical Trials and Potential Medications for Alcohol Dependence: Data Analysis from ClinicalTrials.gov
- SRD5A2 and emerging therapies in androgen-driven disorders
- Does Androgenic Alopecia Aggravate the Risk of Prostate Cancer? Evidence from Mendelian Randomization
- Identification of Potential Cytochrome p450c 17 Alpha Inhibitors for the Treatment of PCOS via Scaffold Hopping and Fragment-Based De-Novo Drug Design
- Insight into Recent Advances in Degrading Androgen Receptor for Castration-Resistant Prostate Cancer
- Prostatakarzinom
- Urological Drug Price Stewardship: Potential Cost Savings Based on the Mark Cuban Cost Plus Drug Company Model
- Abiraterone and spironolactone in prostate cancer: a combination to avoid
- Revising the role of the androgen receptor in breast cancer
- Steroidal 5α-reductase and 17α-hydroxylase/17,20-lyase (CYP17) inhibitors useful in the treatment of prostatic diseases
- Redefining hormone resistance in prostate cancer
- Discovery of clinically approved drugs capable of inhibiting SARS-CoV-2 <i>in vitro</i> infection using a phenotypic screening strategy and network-analysis to predict their potential to treat covid-19
- New insights into molecular signaling pathways and current advancements in prostate cancer diagnostics & therapeutics
- Intratumoral <i>De Novo</i> Steroid Synthesis Activates Androgen Receptor in Castration-Resistant Prostate Cancer and Is Upregulated by Treatment with CYP17A1 Inhibitors
- HSD3B1 Genotypes Conferring Adrenal-Restrictive and Adrenal-Permissive Phenotypes in Prostate Cancer and Beyond
- Hormone Blocking Anticancer Drugs
- Alopecia With Endocrine Therapies in Patients With Cancer
- Reporting on Adverse Clinical Events
- The 5 Alpha-Reductase Isozyme Family: A Review of Basic Biology and Their Role in Human Diseases